News
UCSF Names First-Ever Chief Biobank Officer
Unlocking the potential in biospecimens for medical breakthroughs is among the cornerstones of precision medicine. Signaling its continued commitment to pioneering research, UC San Francisco has appointed Rohit Gupta as its inaugural Chief Biobank Officer (CBO). His appointment, which follows a
From Bacteria to Interstellar Travel - with CRISPR in Between - Luke Gilbert Loves Science!
This week, Luke Gilbert, PhD, Assistant Professor, Department of Urology, and a Goldberg-Benioff Endowed Professor in Prostate Cancer Translational Biology, was named a member of the 2019 class of the Pew-Stewart Scholars Program for Cancer Research. Gilbert was one of seven early-career scientists
New CRISPR Lab to Accelerate Drug Discovery, Advance Genomic Research
GlaxoSmithKline plc (GSK) has launched a five-year, $67 million collaboration with the San Francisco and Berkeley campuses of the University of California to build a state-of-the-art laboratory that will use CRISPR technologies to explore how genes cause disease and to rapidly accelerate the
Mentorship, Collaboration Inspire a Passion for Improving Outcomes for Older Adults with Cancer
Mentorship within a close-knit community is driving interest in the field of geriatric oncology. Dr. Li-Wen Huang, Hematology Oncology Fellow, and Dr. Melisa Wong, Assistant Professor, Division of Hematology/Oncology, and leader of the new UCSF Older Adult Cancer Care Program, credit key individuals
From Bacteria to Outer Space, with CRISPR in Between, Luke Gilbert Loves Science
This week, Luke Gilbert, PhD, Assistant Professor, Department of Urology, and a Goldberg-Benioff Endowed Professor in Prostate Cancer Translational Biology, was named a member of the 2019 class of the Pew-Stewart Scholars Program for Cancer Research. Gilbert was one of seven early-career scientists
ASCO 2019 Roundup: A Year for Twitter
Once again UCSF had an impressive presence at this year's annual meeting of the American Society of Clinical Oncologists (ASCO) in Chicago. One of the world’s most prestigious gatherings of oncology professionals, ASCO 2019 drew more than 40,000 cancer experts focusing on groundbreaking research and
Podcast: Conquering Cancer from Within. Immunotherapy, the new Hope.
Dr. Lawrence Fong, leader of the HDFCCC Cancer Immunotherapy Program, was featured last month on the CureTalks podcast for a live discussion of the latest in cancer immunotherapy research, clinical trials, and treatments. Immunotherapy is a type of cancer treatment that helps your immune system